IE
IMCR icon

Israel Englander’s Immunocore IMCR Stock Holding History

Israel Englander’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.7M Buy
1,597,037
+359,634
+29% +$10.6M 0.02% 883
2026
Q1 		$37.3M Buy
1,237,403
+325,806
+36% +$10.5M 0.02% 1055
2025
Q4 		$31.6M Sell
911,597
-354,368
-28% -$12.5M 0.01% 1140
2025
Q3 		$46M Buy
1,265,965
+989,463
+358% +$33.6M 0.02% 938
2025
Q2 		$8.68M Sell
276,502
-8,768
-3% -$272K ﹤0.01% 2418
2025
Q1 		$8.46M Sell
285,270
-288,092
-50% -$8.64M ﹤0.01% 2356
2024
Q4 		$16.9M Sell
573,362
-103,269
-15% -$3.26M 0.01% 1662
2024
Q3 		$21.1M Buy
676,631
+75,677
+13% +$2.75M 0.01% 1512
2024
Q2 		$20.4M Buy
600,954
+333,167
+124% +$17M 0.01% 1487
2024
Q1 		$17.4M Buy
267,787
+207,789
+346% +$14.3M 0.01% 1673
2023
Q4 		$4.1M Sell
59,998
-129,384
-68% -$6.72M ﹤0.01% 2950
2023
Q3 		$9.83M Buy
+189,382
New +$11.2M 0.01% 2069
2023
Q2 		– Sell
-117,603
Closed -$6.71M – 6376
2023
Q1 		$5.81M Sell
117,603
-220,125
-65% -$12.4M ﹤0.01% 2478
2022
Q4 		$19.3M Buy
337,728
+181,546
+116% +$10.2M 0.01% 1479
2022
Q3 		$7.33M Buy
156,182
+137,004
+714% +$6.53M ﹤0.01% 2515
2022
Q2 		$716K Buy
+19,178
New +$623K ﹤0.01% 4671
2021
Q4 		– Sell
-93,812
Closed -$3.48M – 7073
2021
Q3 		$3.48M Sell
93,812
-9,309
-9% -$314K ﹤0.01% 3298
2021
Q2 		$4.03M Sell
103,121
-100,534
-49% -$3.88M ﹤0.01% 3048
2021
Q1 		$8.67M Buy
+203,655
New +$9.07M 0.01% 1942

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Israel Englander's IMCR Position: Q2 2026 in Review

Israel Englander increased its Immunocore (IMCR) stake by 29% in Q2 2026, buying an estimated $10.6M and bringing the position to 1,597,037 shares worth $50.7M. The position accounts for 0.02% of the portfolio, ranked #883.

Israel Englander first reported a position in IMCR in Q1 2021 and has held it in 19 quarters since. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Israel Englander held 1,597,037 shares of Immunocore worth $50.7M as of Q2 2026.
  • Israel Englander bought 359,634 Immunocore shares in Q2 2026, an estimated $10.6M.
  • Immunocore made up 0.02% of Israel Englander's portfolio in Q2 2026, its #883 holding.
  • Israel Englander first reported a position in Immunocore in Q1 2021 and has held it in 19 quarters since.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.